China Biologic Products Holdings, Inc.
CBPO
CBPO was delisted on the 20th of April, 2021.
78 hedge funds and large institutions have $1.44B invested in China Biologic Products Holdings, Inc. in 2015 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 9 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
144% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 9
67% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 18
51% more capital invested
Capital invested by funds: $953M → $1.44B (+$484M)
20% more funds holding
Funds holding: 65 → 78 (+13)
75% less call options, than puts
Call options by funds: $1.54M | Put options by funds: $6.28M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.3M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$8.7M |
| 3 |
Renaissance Technologies
New York
|
+$5.43M |
| 4 |
JP Morgan Chase
New York
|
+$4.87M |
| 5 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$3.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$3.26M |
| 2 |
Millennium Management
New York
|
-$2.67M |
| 3 |
Morgan Stanley
New York
|
-$2.43M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$2.02M |
| 5 |
NONA
Ninety One North America
New York
|
-$1.26M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCS
76
Crosspoint Capital Strategies
Orinda,
California
| $7K | +$224 | +3 | +4% |
|
77
Creative Planning
Overland Park,
Kansas
| $6K | +$4.49K | +60 | New |
|
|
TRCT
78
Tower Research Capital (TRC)
New York
| $5K | +$4.11K | +55 | New |
|
|
79
Millennium Management
New York
| – | -$2.67M | -39,658 | Closed |
|
|
NONA
80
Ninety One North America
New York
| – | -$1.26M | -18,787 | Closed |
|
|
RFC
81
Russell Frank Company
Seattle,
Washington
| – | -$649K | -9,598 | Closed |
|
|
AAMU
82
Amundi Asset Management US
Boston,
Massachusetts
| – | -$371K | -5,525 | Closed |
|
|
GA
83
Gateway Advisory
Westfield,
New Jersey
| – | -$272K | -4,050 | Closed |
|
|
TI
84
Trexquant Investment
Stamford,
Connecticut
| – | -$208K | -3,100 | Closed |
|
|
RA
85
Royce & Associates
New York
| – | -$195K | -2,900 | Closed |
|
|
BRWA
86
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$113 | -1,669 | Closed |
|
87
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$17K | -250 | Closed |
|
CBPO Hedge Fund Activity: Q1 2015 in Review
78 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q1 2015, worth a combined $1.44B — up 51% from $953M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CBPO positions and 9 closed out — a net gain of 13 holders — while 30 added to existing stakes and 18 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $29.3M. The largest seller was Putnam Investments, cutting an estimated $3.26M.
- 78 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q1 2015, up from 65 in Q4 2014.
- Funds reported $1.44B of China Biologic Products Holdings, Inc. stock for Q1 2015, up 51% quarter-over-quarter.
- 22 funds opened new China Biologic Products Holdings, Inc. positions in Q1 2015 and 9 closed out, a net change of +13 holders.
- The largest China Biologic Products Holdings, Inc. buyer in Q1 2015 was Fidelity Investments, an estimated $29.3M added.
- The largest China Biologic Products Holdings, Inc. seller in Q1 2015 was Putnam Investments, an estimated $3.26M sold.
Based on aggregated 13F filings for Q1 2015.